Gilead CEO breaks down new Trodelvy data in breast cancer patients

Подписаться 2,8 млн

Просмотров 7 тыс.

50% 1

CNBC's Meg Tirrell sits down with Gilead CEO Daniel O’Day amid the American Society of Clinical Oncology conference in Chicago to discuss the company's latest data surrounding its cancer drug Trodelvy. For access to live and exclusive video from CNBC subscribe to CNBC PRO: cnb.cx/2NGeIvi
» Subscribe to CNBC TV: cnb.cx/SubscribeCNBCtelevision
» Subscribe to CNBC: cnb.cx/SubscribeCNBC
Turn to CNBC TV for the latest stock market news and analysis. From market futures to live price updates CNBC is the leader in business news worldwide.
The News with Shepard Smith is CNBC’s daily news podcast providing deep, non-partisan coverage and perspective on the day’s most important stories. Available to listen by 8:30pm ET / 5:30pm PT daily beginning September 30: www.cnbc.com/2020/09/29/the-n...
Connect with CNBC News Online
Get the latest news: www.cnbc.com/
Follow CNBC on LinkedIn: cnb.cx/LinkedInCNBC
Follow CNBC News on Facebook: cnb.cx/LikeCNBC
Follow CNBC News on Twitter: cnb.cx/FollowCNBC
Follow CNBC News on Instagram: cnb.cx/InstagramCNBC
www.cnbc.com/select/best-cred...
#CNBC
#CNBCTV

Опубликовано:

5 июн 2022

Ссылка:

Скачать:

Готовим ссылку...

Добавить в:

Мой плейлист

Посмотреть позже

Комментарии : 5

@carespagpropietas4953 2 года назад

maybe better considering guanabana leaves tea, garlic, curcuma, low carb diet , avoid sugars, exercise (rebounder), and above all prayer and meditation, etc.

@leonardowilson7709 Год назад

This company stock should be at least $150/share

@joepearce3033 2 года назад

Remdesivir..

@ednan9 2 года назад

The drug probably cost $10Million a pill - such are the crazy times we live in - sad

@sirus312 2 года назад

Look at the R&D going into it. IMO we should be covering these treatments and cutting other useless gov't programs just to keep people on life support. Most americans aren't putting in the work to keep this country above water, they are takers